ω-3 Fatty Acids and Nonalcoholic Fatty Liver Disease

2014 ◽  
pp. 268-301
Keyword(s):  
Fatty Acids ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Nonalcoholic Fatty Liver

The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease

2011 ◽  
Vol 30 (1) ◽  
pp. 6-19 ◽  
Author(s):  
Haim Shapiro ◽  
Miryam Tehilla ◽  
Joelle Attal-Singer ◽  
Rafael Bruck ◽  
Rachel Luzzatti ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Therapeutic Potential ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Nonalcoholic Fatty Liver ◽  
Long Chain

Đường ngọt: thừa cân, béo phì và đái tháo đường

2019 ◽  
Author(s):  
Bá Thoại Trần
Keyword(s):  
Fatty Acids ◽  
Liver Disease ◽  
Fatty Liver ◽  
Free Fatty Acids ◽  
Nonalcoholic Fatty Liver Disease ◽  
Key Words ◽  
Fatty Liver Disease ◽  
Nonalcoholic Fatty Liver

Sugary carbohydrates in foods are sweet-tasted carbohydrates of mono or disacchride, most commonly is saccharose (sucrose). This is a disaccharide consisting of two molecules of glucose and fructose.While glucose is completely metabolized in all body cells to produce energy, fructose is metabolized differently in the liver causing nonalcoholic fatty liver disease and free fatty acids in the blood …. and causing many complications. Key words: Sugary carbohydrate, diabetes, overweight, obesity

Splanchnic Balance of Free Fatty Acids, Endocannabinoids, and Lipids in Subjects With Nonalcoholic Fatty Liver Disease

2010 ◽  
Vol 139 (6) ◽  
pp. 1961-1971.e1 ◽  
Author(s):  
Jukka Westerbacka ◽  
Anna Kotronen ◽  
Barbara A. Fielding ◽  
John Wahren ◽  
Leanne Hodson ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Liver Disease ◽  
Fatty Liver ◽  
Free Fatty Acids ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Nonalcoholic Fatty Liver

scholarly journals Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD)

2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Dominika Maciejewska ◽  
Wojciech Marlicz ◽  
Karina Ryterska ◽  
Marcin Banaszczak ◽  
Dominika Jamioł-Milc ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Acid Profile ◽  
Fatty Liver Disease ◽  
Dietary Intervention ◽  
Erythrocyte Membranes ◽  
Nonalcoholic Fatty Liver

Background. Nonalcoholic fatty liver disease (NAFLD) is closely related to the metabolism disorders of fatty acids. The pathogenesis of the disease includes an increased concentration of FFA in blood, an increase in the biosynthesis of fatty acids, and disorders in the process of β-oxidation. Objective. The aim of the study was to analyze the fatty acids in erythrocyte membranes among 55 patients with NAFLD who were subjected to a 6-month dietary intervention in order to reduce fatty liver. Materials and Methods. Basic anthropometric and biochemical measurements were performed. The profile of fatty acids was measured in the membranes of erythrocytes and analyzed by gas chromatography. The dietary compliance was evaluated using 72-diary questionnaires, anthropometric measurements. Results. With the reduction of fatty liver (p<0.01), the patients’ biochemical and anthropometric parameters were significantly improved. A significant decrease in the concentration of alanine aminotransferase (p<0.01) and asparagine aminotransferase (p<0.01) was observed, along with a decrease in the amount of insulin (p<0.05) and insulin resistance (p<0.05). Significant changes in terms of the fatty acid profile were observed among patients who followed the dietary intervention. There was a noticeable tendency in terms of the reduction palmitic acid (p<0.055) and a significant reduction of stearic acid (p<0.05). Significant changes in the profile of fatty acids were also associated with the reductionof palmitoleic (p<0.05) and oleic acids (p<0.05). Another statistically significant change observed was the increase in polyunsaturated fatty acids. In particular (p<0.01) the rise of eicosapentaenoic (p<0.055) and docosahexaenoic acids (p<0.55) was noted. Conclusion. The profile of fatty acids turned out to be a potential biomarker of the liver changes during NAFLD regression. Further research is needed to fully elucidate the usefulness and applicability of our findings in the management of NAFLD.

Sign in / Sign up

Export Citation Format

Share Document